UCLA David Geffen School of Medicine

Santa Monica, California 90404

2 studies enrolling now · 3 studies all time

What they study most

Advanced Lung Cancer, Breast Neoplasms, Carcinoma, Ductal, Breast, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Intrahepatic, Gallbladder Adenocarcinoma, Receptors, Estrogen (for ER-positive Requirement)

Studies at this site

• A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer — Recruiting now
• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer — Recruiting now
• Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma — Stopped early